POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
UNI - EN REPORT No | 69 | / | 2021 | ||||||||
Date of issue: | 2021-09-09 | ||||||||||
Short name of the issuer | |||||||||||
SOPHARMA AD | |||||||||||
Subject | |||||||||||
Notification under Art. 111 para. 6 of LPOS for repurchase of shares | |||||||||||
Official market - legal basis | |||||||||||
art. 56. 1. 2 of Act on Public Offering. | |||||||||||
Unofficial market - legal basis | |||||||||||
Contents of the report: | |||||||||||
“Sopharma” AD (the Company) notifies that on the basis of Art. 187b of the Commercial Law and Art. 111 para. 5 and para. 6 of LPOS and in connection with a decision of the General Meeting of the company held on February 23, 2018 and a decision of the Board of Directors of September 9, 2021, “Sopharma” AD notifies that the company intends to buy its own shares in the restriction under Art. 111 para. 5 of LPOS, as follows: - Number of shares subject to repurchase - up to 350,000 (three hundred and fifty thousand) shares; - Repurchase price - BGN 3.66 per share of the company's capital; - Repurchase date: September 10, 2021; - Licensed investment intermediary who has been given the purchase order - "First Financial Brokerage House" ООD. | |||||||||||
Annexes | |||||||||||
File | Description | ||||||||||
SFA_buy-back_10092021_EN.pdf | Notification under Art. 111 para. 6 of LPOS for repurchase of shares |
SOPHARMA AD | |||||||||||||
(fullname of the issuer) | |||||||||||||
SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
(short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
1220 | Sofia | ||||||||||||
(post code) | (city) | ||||||||||||
IlienskoShosse | 16 | ||||||||||||
(street) | (number) | ||||||||||||
+359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
(phone number) | (fax) | ||||||||||||
(e-mail) | (web site) | ||||||||||||
nd | |||||||||||||
(NIP) | (REGON) |
SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
Date | Name | Position / Function | Signature | ||
2021-09-09 | Ognian Donev | Executive Director |